North Central Center for Mental Wellness

North Central Center for Mental Wellness

How to get started with SPRAVATO®

1. Getting Started with SPRAVATO®

Your journey begins with a conversation with one of our intake specialists, who will gather basic information and schedule a consultation with a dedicated Consult Coordinator. Whether in person, via video call, or over the phone, your Consult Coordinator will take the time to review your medical history, answer your questions, and guide you through the key aspects of esketamine nasal spray treatment.

2. Pre-Assessment: Is SPRAVATO® Right for You?

Next, you'll meet with a qualified healthcare provider for a thorough evaluation, which will include a review of your medical history and symptoms.

If the provider determines that SPRAVATO® is a suitable treatment for you and you're ready to move forward, they will develop a personalized treatment plan tailored to your needs.

3. Treatment: Begin Your Journey to Relief

When you arrive, you'll be seated in a comfortable reclining chair where you can relax. You'll self-administer the nasal spray under the supervision of your care team, who will monitor you for at least two hours to ensure your safety. After treatment, a trusted friend or family member will need to drive you home. By the next morning, most patients can resume their daily activities without restrictions.

SPRAVATO® Treatment Phases

  • Phase One

    Week 1-2

    Two treatments each week

  • Phase Two

    Week 5-8

    1 treatment each week

  • Phase Three

    Week 9+

    One treatment every 1 -2 weeks

Frequently asked questions

  • SPRAVATO® is an FDA-approved esketamine nasal spray, a specialized form of ketamine, used to treat adults with treatment-resistant depression and depressive symptoms in those with major depressive disorder (MDD) experiencing suicidal thoughts or actions. It is also covered by most major insurance plans.

    In contrast, ketamine itself is not FDA-approved for these conditions and is often not covered by insurance.

  • Yes. SPRAVATO® can be administered as a stand-alone therapy or combined with other oral antidepressant medications. Our psychiatric professionals will work with you to determine the best approach for your needs.

  • SPRAVATO® Is an FDA-approved esketamine nasal spray used to treat adults with major depressive disorder who have not received adequate relief after two or more oral antidepressant trials. 

  • Your provider will determine the dose of SPRAVATO® based on your treatment plan. There will be 2-3 sprays self-administered in each nostril, depending on the dose prescribed by your provider.

  • No, esketamine nasal spray is FDA-approved for adults with major depressive disorder who have not found sufficient relief with traditional antidepressant medications.